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Background: Routine intra-operative cholangiography (IOC) during laparoscopic cholecystectomy is
often not performed because of increased operative time, radiation, and failure rate. Laparoscopic ul-
trasound (LUS) is a less invasive alternative but studies comparing it to IOC have been of small sample
size. This study aims to assess the diagnostic accuracy of LUS in detecting common bile duct (CBD) stones
compared to IOC.
Methods: This meta-analysis was executed and reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta- Analyses (PRISMA) statement. 11 comparative studies (1994e2013)
reporting on 12 patient groups were included. A bivariate model for diagnostic meta-analysis was used to
attain overall pooled sensitivity and speciﬁcity for IOC and LUS, and their relationship assessed using a
hierarchical summary receiver operating characteristic model with meta-regression.
Results: IOC had a pooled sensitivity of 0.87 (95% CI 0.77e0.93) and a pooled speciﬁcity of 0.99 (95% CI
0.98e0.99) with no signiﬁcant heterogeneity. The diagnostic Odds Ratio (OR) was 442 (95% CI 196e997)
and pooled weighted Area Under the Curve (AUC) was 0.99 (95% CI: 0.98e1.0). LUS had a pooled
sensitivity of 0.87 (95% CI 0.80e0.92) and a speciﬁcity of 1.00 (95% CI 0.99e1.00). Heterogeneity was
signiﬁcant for speciﬁcity results. The diagnostic Odds Ratio (OR) was 1171 (95% CI 372e3689) and the
pooled, weighted AUC was 1 (95% CI: 0.99e1). Meta-regression did not identify factors that signiﬁcantly
predict diagnostic accuracy.
Conclusions: LUS is a potentially useful imaging modality to conﬁrm the absence of CBD stones without
needing to cannulate the biliary system.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Routine intra-operative visualisation of the common bile duct
(CBD) during laparoscopic cholecystectomy through intra-operative
cholangiography (IOC) remains a controversial issue. A recent sys-
tematic review of 8 randomised controlled trials (1715 patients) did
not identify sufﬁcient evidence to support or abandon the use of IOC
in preventing retained common bile duct stones [1]. The selective
use of IOC has been suggested in cases where CBD anatomy is either).
by Elsevier Ltd. All rights reservedunclear or as a prerequisite to CBD exploration, but a growing
number of surgeons are abandoning IOC and instead using pre-
operative non-invasive imaging with magnetic resonance chol-
angiopancreatography (MRCP) to detect choledocholithiasis. A
recent study from Texas showed a wide variation in IOC use across
the state, ranging from 2.4% to 98.4% of cases among surgeons and
3.7%e94.8% of cases among hospitals [2]. In the UK, a 2010 Associ-
ation of Upper Gastro-Intestinal Surgeons of Great Britain and
Ireland (AUGIS) survey found that only 24% advocated routine IOC
during laparoscopic cholecystectomy [3]. Patients at higher risk of
CBD stones include those with pancreatitis, persistently elevated
bilirubin and alkaline phosphatase, or CBD dilatation on trans-.
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presence of a CBD stone, which can be cleared with pre-operative
endoscopic retrograde cholangiopancreatography (ERCP). As a
result, laparoscopic CBD exploration has become an unfamiliar
procedure to the majority of surgeons undertaking laparoscopic
cholecystectomies. Furthermore, in caseswhere choledocholithiasis
is detected after cholecystectomy, post-operative duct clearance
with ERCP can be performed [5,6].
There exists however a risk of undetected CBD stones at time of
cholecystectomy despite pre-operative investigation. This may be
as a result of recurrent choledocholithiasis in the interval between
investigation and cholecystectomy, or because CBD stones were not
suspected at presentation and an MRCP was not performed. A
recent systematic review of randomised trials of IOC versus no IOC
during cholecystectomy has suggested that CBD stones are present
in 2.7% of patients at laparoscopic cholecystectomy despite pre-
operative ductal imaging and clearance with ERCP [1].
The question is what intra-operative CBD assessment tools can
most effectively beused to detect choledocholithiasis at laparoscopic
cholecystectomy? Whilst the IOC is ideally suited to this role, its
utility has reduced amongst surgeons because of the increased
operative time (by a mean of 16 min), radiation exposure, increased
cost, and failure rate [1]. A less invasive, expensive, and time-
consuming mode of intra-operative CBD assessment through lapa-
roscopic ultrasound (LUS) has been available for over a decade [7].
The technique utilises the same port placements as for a standard
laparoscopic cholecystectomy. A ﬂexible ultrasound probe is placed
through the umbilical port, while the camera is placed through the
epigastric port. The CBD is identiﬁed by scanning the liver and is
placed medial to the gallbladder. The gallbladder is retracted ceph-
alad and the transducer placed directly over the CBD. The junction of
the right and left hepatic ducts and the cystic duct junction can then
beseen. TheCBD is then followed to theduodenum,with a transverse
view of the CBD obtained by ﬂexing the transducer tip.
Whilst a number of studies have compared LUS to IOC in the
detection of choledocholithiasis, this assessment has to date been
inadequate largely due to small sample size, resulting in an un-
certainty as to whether they are comparable imaging modalities.
This study aims to assess the diagnostic accuracy of LUS in detecting
choledocholithiasis compared to IOC as well as identifying any
parameters that contribute its accuracy.
2. Materials and methods
The study was executed and reported in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta- Ana-
lyses (PRISMA) statement [8]. All comparative studies (without
language restriction) published between 1994 and 2013 investi-
gating LUS versus IOC during laparoscopic cholecystectomy were
identiﬁed. MEDLINE, EMBASE, Cochrane library, Health Technology
Assessment, clinicaltrials.gov, World Health Organisation database
of clinicaltrials, and Google Scholar online databases were searched
using the following key words and Medical Subject Headings
(MESH): “cholecystectomy/laparoscopic”, “Bile ducts ultrasonog-
raphy”, “cholangiography”, “common bile duct/ultrasonography”,
“gallstones/ultrasonography”, “gallstones/radiology”, and “sensi-
tivity/speciﬁcity”. The ‘related articles’ function and reference list
of each of the identiﬁed publication was used to further widen the
literature search. Any relevant review articles were also screened.
2.1. Study selection and data extraction
Two authors (OA and HA) independently performed the litera-
ture search and data extraction. Inclusion/exclusion criteria and
outcomes of interest are described below. Study quality wasindependently assessed using a tool for the Quality Assessment of
Diagnostic Accuracy Studies (QUADAS 1 and 2) [9,10]. Conﬂicts in
data extraction were resolved by a third reviewer (TA).
2.2. Inclusion & exclusion criteria
In order to be included, studies had to: 1. Involve prospective
data collection; 2. Include participants undergoing laparoscopic
cholecystectomy for choledocholithiasis; 3. Attempt both LUS and
IOC on all patients; 4. Compare LUS and IOC to the gold standard
(deﬁned as IOC with or without CBD exploration and no post-
operative evidence of retained CBD stones over time); and 5. Pro-
vide enough data for sensitivity, speciﬁcity, true positive, true
negative, false positive, and false negative results for each investi-
gation. The gold standard to which LUS and IOC were compared
was negative intra-operative LUS and IOC, plus an absence of post-
operative episodes of deranged liver function tests (in particular a
bilirubin rise), pancreatitis, or post-operative ERCP during this
period. If CBD stones were seen on intra-operative IOC or LUS, the
gold standard was direct visualisation of the CBD with laparoscopic
exploration, intra- or post-operative ERCP. ‘True positives’ were
identiﬁed as patients who had a CBD stone identiﬁed by LUS or IOC
and conﬁrmed on gold standard. ‘False positives’ were patients in
whom LUS or IOC identiﬁed a CBD stone but the gold standard did
not. ‘True negatives’ were patients who were found not to have
gallstones present on IOC or LUS at the time of laparoscopic cho-
lecystectomy and subsequently did not develop liver function test
derangement. Finally ‘false negatives’ were patients in whom IOC
and LUS failed to detect CBD stones, but theywere later foundwhen
the patient developed deranged liver function tests or abdominal
pain as a result of which post-operative ERCP was performed.
Studies were excluded if: 1. They included patients undergoing
open cholecystectomy; 2. They reported on a previously reported
dataset (in this case the larger and better quality paper was used);
3. They compared the diagnostic accuracy of LUS and IOC per-
formed in different patient groups; 4. They reported only sensitivity
and speciﬁcity but did not provide data from which true positive,
true negative, false positive, and false negative results for each
investigation could be determined; and 5. LUS was performed by a
novice operator (less than 20 cases).
2.3. Outcome measures
The primary outcome of interest was the presence or absence of
CBD stones. Additional data extracted from each paper included:
year of publication, study design, and feasibility of LUS versus IOC.
An assessment of diagnostic accuracy was made to examine the
effects of the following: Type of LUS probe used, proportion of
patients with acute cholecystitis, operator experience, pre-
operative ERCP performed, and time taken to perform LUS or IOC.
2.4. Statistical analysis
The bivariate model for diagnostic meta-analysis was used to
attain overall pooled sensitivity (true positive/[true positive þ false
negative]) and speciﬁcity (true negative/[true negative þ false
positive]) [11]. This has the advantage of using pairs of sensitivity
and speciﬁcity as the starting point of analysis. It also incorporates
study sample size and takes into account negative correlation be-
tween sensitivity and speciﬁcity of the index test within studies.
We used a mixed effects model. If less than four studies reported an
outcomemeasure, it was not included in the meta-analysis because
the bivariate model fails to converge with small numbers of studies
[12]. The relationship between sensitivity and speciﬁcity was also
Fig. 1. Flow chart of studies included in this analysis.
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teristic (HSROC) model [13,14].
A prediction region (within the prediction curves) was also
produced and represents the probability of including the true
sensitivity and speciﬁcity of a future study. The diagnostic rigour of
IOC and LUS over study groups was assessed using the pooled area
under SROC curves. Heterogeneity was assessed using I2 (25e49%
was considered a low level of heterogeneity, 50e74% was consid-
ered as moderate level of heterogeneity, and >75% was considered
as a high degree of heterogeneity).
Trapezoidal integration (using themidas command) was used to
calculate the pooled area under the curve (AUC), where 0.5 implies
that a test was equally likely to diagnose a positive result as either
positive or negative and a value of 1.0 indicates a ‘perfect’ test that
gives a 100% correct diagnosis, regardless of patient demographics.
This technique has some limitations as it may give misrepresen-
tative results where there are relatively small numbers of studies
[15]. Pragmatically, tests will have a variable pooled AUC value and
tend towards 1.0 as diagnostic accuracy improves; a pooled AUC of
greater than 0.75e0.92 represents a good degree of diagnostic ac-
curacy (as opposed to 0.93e0.96 which is considered very good)
[16]. Although the AUC has some limitations it has some practical
utility in this clinical context. This is not a direct comparison and
the analysis has not been done with both modalities in the same
hierarchical model. We used Stata version 10.0 (StataCorp, College
Station, Texas) using the midas and metandi commands for all
statistical analyses [17,18].
Meta-regression analysis was performed incorporating age, in-
clusion of patients with acute cholecystitis, pre-operative ERCP,
ﬂexible tip ultrasound probe, and study quality (QUADAS-1 score).
This study was undertaken in accordance with reported guidance
for diagnostic test meta-analyses [19,20]. Cook's distance was
calculated to assess for inﬂuential studies and Deek's test was
calculated to assess for publication bias whichwas performed using
regression of diagnostic log odds ratio against 1/sqrt (effective
sample size) with weighting by effective sample size. P < 0.10 for
the slope coefﬁcient was used to indicate signiﬁcant asymmetry
[21,22]. Fagan’s nomograms were drawnwith left axis representing
the pre-test probability, middle axis representing the likelihood
ratio and right axis representing the post-test probability [23].
3. Results
Forty-nine papers reporting on the diagnostic accuracy of IOC
versus LUS in the detection of choledocholithiasis during laparo-
scopic cholecystectomy were identiﬁed. Twenty-three of these
were excluded because LUS and IOC were not performed on the
same patients. A further eight were excluded because they reported
on the same patient group. In these cases, the most recent study
with the largest and most complete dataset was selected for in-
clusion. Six studies were excluded because it was impossible to
calculate TP/TN/FP/FN rates for LUS and IOC using the data pre-
sented. Finally one study was excluded because LUS was performed
by novices. The remaining 11 studies were included in this analysis
as outlined in Fig. 1 [2434]. One of these studies included two
separate patient groups in whom the diagnostic accuracy of LUS
versus IOC was compared [26]. The characteristics of the 12
included patient groups from these 11 studies is presented in
Table 1, with the results of their QUADAS-2 evaluation presented in
Table 2.
3.1. Ability to detect CBD stones: IOC
IOC had a pooled sensitivity of 0.87 (95% CI 0.77e0.93) and a
pooled speciﬁcity of 0.99 (95% CI 0.98e0.99) in its ability to detectCBD stones during laparoscopic cholecystectomy. Heterogeneity
was not found to be signiﬁcant for the sensitivity (Cochran Q
test ¼ 19.90, p ¼ 0.05, I2 ¼ 44.71%), or speciﬁcity results (Cochran Q
test ¼ 14.86, p ¼ 0.19, I2 ¼ 25.98%). IOC had a pooled positive
likelihood ratio of 59.7 (95% CI 39.71e89.66) and a pooled negative
likelihood ratio of 0.14 (95% CI 0.08e0.24). The diagnostic Odds
Ratio (OR) was 442 (95% CI 196e997). The pooled, weighted AUC
was 0.99 (95% CI: 0.98e1.0). Deeks' funnel plot asymmetry test
identiﬁed 4 outliers as shown in Fig. 2 [25,27,30,33]. Subgroup
analysis following exclusion of these outliers showed a pooled
sensitivity of 0.80 (95% CI 0.73e0.86) and a speciﬁcity of 0.98 (95%
CI 0.97e0.99) for IOC in its ability to detect CBD stones during
laparoscopic cholecystectomy. Furthermore in the subgroup anal-
ysis IOC had a pooled positive likelihood ratio of 44.8 (95% CI
28.8e69.9) and a pooled negative likelihood ratio of 0.20 (95% CI
0.14e0.28). The diagnostic Odds Ratio (OR) was 225 (95% CI
127e399) and the pooled, weighted AUC was 0.99 (95% CI:
0.97e0.99).
Fig. 3 shows the bivariate summary receiver operating charac-
teristic (SROC) and the hierarchical summary receiver operating
characteristic (HSROC) graphs with 95% conﬁdence region and 95%
prediction region for IOC. The area under the SROC curve was 0.99
(95% CI 0.98e1). The theta and lambda data for the HSROC curve are
presented in Table 3. Fig. 4a is a Fagan’s nomogram illustrating the
relations between pre-test and post-test probabilities and likeli-
hood ratio.3.2. Ability to detect CBD stones: LUS
LUS had a pooled sensitivity of 0.87 (95% CI 0.80e0.92) and a
speciﬁcity of 1.00 (95% CI 0.99e1.00) in its ability to detect CBD
stones during laparoscopic cholecystectomy. Heterogeneity was
not found to be signiﬁcant for the sensitivity (Cochran Q
test¼ 14.79, p¼ 0.19, I2¼ 25.61%) but it was however signiﬁcant for
speciﬁcity results (Cochran Q test ¼ 33.32, p ¼ 0.00, I2 ¼ 66.99%).
LUS had a pooled positive likelihood ratio of 420.6 (95% CI
64.2e2756.7) and a pooled negative likelihood ratio of 0.13 (95% CI
0.09e0.20).
The diagnostic Odds Ratio (OR) was 3174 (95% CI 390e25859).
The pooled, weighted AUC was 0.97 (95% CI: 0.96e0.98). Deeks’
funnel plot asymmetry test identiﬁed 3 outliers as shown in Fig. 5
[25,30,33]. Subgroup analysis following exclusion of these outliers
showed a pooled sensitivity of 0.87 (95% CI 0.79e0.92) and a
speciﬁcity of 0.99 (95% CI 0.99e1) for LUS in its ability to detect CBD
Table 1
Characteristics of studies included in this analysis.
Author Design Patients with
LUS & IOC
Reference standard M/F ratio LUS probe IOC type Time taken (min)
Catheline (2002) PNR 762 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:2.5 Side viewing ﬂexible Digital LUS: Median 9.8 (4e21)
IOC: Median 17.6 (7e42)
Birth (1998) PR 477 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:3.1 Side viewing ﬂexible Digital LUS: Mean ¼ 7
IOC: Mean ¼ 16
Siperstein (1999) PNR 282 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
N/A Mixed Digital LUS: N/A
IOC: N/A
Rijna (1999) PNR 38 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:2.6 Side viewing rigid Digital LUS: Mean ¼ 16 (±8)
IOC: Mean ¼ 18 (±7)
Tranter (2003) PNR 121 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:3.4 Side viewing rigid Digital LUS: N/A
IOC: N/A
Machi (1999) PNR 92 CBD exploration or Postop ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:2.4 Side viewing ﬂexible Digital LUS: Mean ¼ 8.2(±3.5)
IOC: Mean ¼ 15.9 (±6.8)
Goletti (1995) PNR 45 Postoperative ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:1.3 Side viewing ﬂexible Digital LUS: Median ¼ 9 (6e15)
IOC: N/A
Greig (1994) PNR 48 CBD exploration or Postop ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:3.5 Side viewing rigid Film LUS: Median ¼ 30 (5e30)
IOC: N/A
Rothlin 1 (1996) PNR 93 Postoperative ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:1.5 side viewing ﬂexible Digital LUS: Mean ¼ 5.4 (±2.4)
IOC: Mean ¼ 16.4 (±7.4)
Rothlin 2 (1996) PNR 90 CBD exploration or Postop ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:2.7 Side viewing ﬂexible Digital LUS: Mean ¼ 4.5 (±1.7)
IOC: Mean ¼ 13.5 (±4.5)
Li (2009) PNR 94 CBD exploration or Postop ERCP (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:1.7 Side viewing ﬂexible Digital LUS: Mean ¼ 8.5 (±1.9)
IOC: Mean ¼ 13.8 (±3.7)
Barteau (1995) PNR 123 CBD exploration (IOC/LUS þ ve)
Post-operative follow-up (IOC/LUS e ve)
1:2.7 Side viewing rigid Digital LUS: Mean ¼ 6.6 (±0.3)
IOC: Mean ¼ 10.0 (±0.6)
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subgroup analysis LUS had a pooled positive likelihood ratio of
154.4 (95% CI 60.9e391.7) and a pooled negative likelihood ratio of
0.13 (95% CI 0.08e0.22). The diagnostic Odds Ratio (OR) was 1171
(95% CI 372e3689) and the pooled, weighted AUC was 1 (95% CI:
0.99e1).
Fig. 6 shows the bivariate summary receiver operating charac-
teristic (SROC) and the hierarchical summary receiver operating
characteristic (HSROC) graphs with 95% conﬁdence region and 95%
prediction region for LUS. The area under the SROC curve was 1
(95% CI 0.99e1). The theta and lambda data for the HSROC curve are
presented in Table 3. Fig. 4b is a Fagan's nomogram illustrating the
relations between pre-test and post-test probabilities and likeli-
hood ratio.Table 2
Quality assessment of diagnostic accuracy studies (QUADAS-2). ¼ Low risk, ¼ High R
Author Risk of bias













We performed a meta-regression analysis incorporating age,
inclusion of patients with pancreatitis, inclusion of patients with
acute cholecystitis, pre-operative ERCP performed, ﬂexible tip ul-
trasound probe, and study quality (total QUADAS-1 score), the re-
sults of which are shown in Table 4. In all outcome measures none
of these parameters were demonstrated as signiﬁcant predictors of
imaging accuracy.4. Discussion
This is the ﬁrst meta-analysis comparing the diagnostic accuracy
of LUS and IOC in detecting CBD stones at the time of laparoscopicisk, ¼ Unclear Risk.
Applicability concerns
Flow and timing Patient selection Index test Reference standard
Fig. 2. Deeks' funnel plot asymmetry test for studies reporting results of IOC. The 4 outliers are marked with an arrow [25,27,30,33].
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means of detecting choledocholithiasis intra-operatively (pooled
sensitivity of 0.87, speciﬁcity of 1.00, diagnostic OR of 1171 and a
pooled weighted AUC of 1) when compared to IOC (pooled sensi-
tivity of 0.87, speciﬁcity of 0.99, diagnostic OR of 225, and a pooled
weighted AUC of 0.99). It is important to note that this study did not
set out to determine the accuracy of LUS and IOC in determining
correct biliary anatomy in order to allow safe clipping of the cystic
duct and injury to the CBD. This is another advantage of intra-
operative CBD visualisation that IOC and LUS potentially offer.
Whilst our study does not lend weight to either side of the
argument on whether routine intra-operative imaging of the CBDFig. 3. Bivariate summary receiver operating characteristic (SROC) and the hierarchical sum
95% prediction region for IOC.should take place, it demonstrates that for those surgeons who feel
unhappy performing IOC, there exists in LUS a non-invasive alter-
native which takes less time to perform. Whilst it has been sug-
gested that LUS is a less expensive procedure than IOC [35,36], this
is unlikely to drive its uptake as the cost of IOC is not prohibitive. A
barrier to adoption that will ultimately determine whether LUS is
adopted however is that LUS requires speciﬁc training.Wewere not
able to quantify the learning curve for LUS as we included only
studies where an experienced operator was performing the
investigation.
Our study was not signiﬁcantly limited by heterogeneity, with
Deeks' funnel plot asymmetry test identifying 4 outliers for IOC andmary receiver operating characteristic (HSROC) graphs with 95% conﬁdence region and
Table 3
Theta and lambda data for the HSROC curves for IOC and LUS.
Lambda Theta Z
Coefﬁcient SE 95% CI Coefﬁcient SE 95% CI
IOC 8.89 4.43 0.21e17.58 3.45 2.80 8.93e2.04 0.98
LUS 6.82 0.80 5.25e8.34 0.06 1.01 2.04e1.91 1.70
Fig. 4. Fagan's nomograms for the prediction of CBD stones by IOC (left) and LUS (right) for a hypothetical patient with a 20% pre-test probability of CBD stones, illustrating the
relations between pre-test and post-test probabilities and likelihood ratio.
Fig. 5. Deeks' funnel plot asymmetry test for studies reporting results of LUS. The 3 outliers are marked with an arrow [25,30,33].
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Fig. 6. Bivariate summary receiver operating characteristic (SROC) and the hierarchical summary receiver operating characteristic (HSROC) graphs with 95% conﬁdence region and
95% prediction region for LUS.
Table 4
Metaregression analysis results for LUS and IOC.
Parameter No of studies Modality Sensitivity (95% CI) Speciﬁcity (95% CI) Heterogeneity (Chi2) p value I2
Age 12 IOC 0.87 (0.77e0.92) 0.98 (0.97e0.99) 117.05 0.000 95
8 LUS 0.83 (0.73e0.90) 0.99 (0.98e1) 1.45 0.48 0
Includes Cholecystitis 12 IOC 0.86 (0.27e0.99) 0.92 (0e1) 52.13 0.00 96
8 LUS 0.99 (0e1) 0.92 (0e1) 35.2 0.00 94
Pre-op ERCP 9 IOC 1.0 (0e1) 0.02 (0e1) 36.61 0.00 95
8 LUS 0.86 (0e1) 0.87 (0e1) 27.8 0.00 93
Flexible tip USS 12 IOC 0.93 (0.8e0.98) 0.99 (0.97e1) 9.79 0.01 79
8 LUS 0.89 (0.64e0.97) 1 (0.79e1) 7.23 0.03 72
QUADAS-2 score 9 IOC 0.83 (0.74e0.89) 0.98 (0.98e0.99) 0.41 0.819 95
8 LUS 0.86 (0.54e0.97) 1 (0.98e1) 4.6 0.1 57
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not signiﬁcantly alter the ﬁndings. Furthermore we evaluated
trends amongst subgroups with meta-regression analysis, which
was not able to identify any speciﬁc aspects that could predict
increased diagnostic accuracy. Factors such as change in the CBD
diameter due to age, the presence of inﬂammation due to acute
cholecystitis, having a pre-operative ERCP, and the type of laparo-
scopic ultrasound probe used would have been expected to impact
the diagnostic performance of LUS and IOC but our results do not
clearly demonstrate this. It may however be because our strict in-
clusion criteria resulted in a small sample size and a relatively
homogenous patient group. This is also reﬂected by the fact that the
studies included in this analysis were of a relatively high quality as
evaluated by QUADAS 1 and 2 (Table 2).
When considering our results it is important to note a number of
limitations: First, the deﬁnition of a ‘true negative’ result was the
absence of CBD stones on IOC and LUS at the time of laparoscopic
cholecystectomy as well without liver function test derangement in
the post-operative period. This was a deﬁnition that we found
universally adopted by the studies included, which is understand-
able as a CBD exploration is not justiﬁed on ethical grounds in these
patients. The length of follow-up for determining whether these
patients developed CBD stones however was not clear and there-
fore a potential source of bias. As a result it has to be appreciated
that there may be a small proportion of patients with retained CBD
stones in the true negative group. Second, there was some variation
in the types of LUS probe used, and whilst we were able to classifythem as ﬂexible or rigid tip, front or side-viewing, there are likely to
be other variations in LUS devices that were not accounted for.
Finally, this study was not adequately powered to determine dif-
ferences between the different types LUS probes used and these
results must be treated with caution.
Despite the above-mentioned limitations our data suggests that
LUS is a potentially useful modality to conﬁrm the absence of CBD
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